Efficacy of electroconvulsive therapy in fahr disease associated with bipolar psychotic disorder: A case report

Journal of ECT

Volumn 25, Issue 3, 2009, Pages 213-215

  Casamassima, Francesco ^a,b   Lattanzi, Lorenzo ^a   Perlis, Roy H ^b,c   Fratta, Sara ^a   Litta, Antonella ^a   Longobardi, Antonio ^a   Stange, Jonathan P ^b   Tatulli, Alessandro ^a   Cassano, Giovanni B ^a  

^a UNIVERSITY OF PISA   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bipolar disorder; Electroconvulsive therapy; Fahr disease

Indexed keywords

AMITRIPTYLINE; DELORAZEPAM; GABAPENTIN; LORAZEPAM; NORTRIPTYLINE; PAROXETINE; PERPHENAZINE; TRANYLCYPROMINE PLUS TRIFLUOPERAZINE;

AGED; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CASE REPORT; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COGNITION; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG SUBSTITUTION; ELECTROCONVULSIVE THERAPY; FAHR DISEASE; FEMALE; HUMAN; MAINTENANCE THERAPY; MENTAL DISEASE; MOOD; PARKINSONISM; PSYCHOSIS; QUALITY OF LIFE; TREATMENT FAILURE; TREATMENT RESPONSE;

AFFECT; AGED; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; ANXIETY; BASAL GANGLIA DISEASES; BIPOLAR DISORDER; CALCINOSIS; COGNITION; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MOVEMENT;

EID: 70349135534     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181914d28     Document Type: Article

References (22)

1. Fahr T. Idiopathische verkalkung der hirngefäβe. Centralbl Allgem Pathol Pathol Anat. 1930;50:129-133.
2. Trautner RJ, Cummings JL, Read SL, et al. Idiopathic basal ganglia calcification and organic mood disorder. Am J Psychiatry. 1988; 145:350-353.
3. Casanova MF, Araque JM. Mineralization of the basal ganglia: implications for neuropsychiatry, pathology and neuroimaging. Psychiatry Res. 2003;121:59-87. Review.
4. Lauterbach EC, Cummings JL, Duffy J, et al. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 1998;10:249-266. Review.
5. Ring HA, Serra-Mestres J. Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry. 2002;72:12-21. Review.
6. Ellie E, Julien J, Ferrer X. Familial idiopathic striopallidodentate calcifications. Neurology. 1989;39:381-385.
7. Manyam BV, Bhatt MH, Moore WD, et al. Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol. 1992;31:379-384.
8. Manyam BV. What is and what is not 'Fahr's disease'. Parkinsonism Relat Disord. 2005;11:73-80.
9. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 1994;6:358-370. Review.
10. López-Villegas D, Kulisevsky J, Deus J, et al. Neuropsychological alterations in patients with computed tomography-detected basal ganglia calcification. Arch Neurol. 1996;53:251-256.
11. Shakibai SV, Johnson JP, Bourgeois JA. Paranoid delusions and cognitive impairment suggesting Fahr's disease. Psychosomatics. 2005;46:569-572.
12. Cunningham SJ, Anderson DN. Delusional depression, hyperparathyroidism, and ECT. Convuls Ther. 1995;11:129-133.
13. Mitchell IJ, Cooper AJ, Griffiths MR. The selective vulnerability of striatopallidal neurons. Prog Neurobiol. 1999;59:691-719.
14. Wojda U, Salinska E, Kuznicki J. Calcium ions in neuronal degeneration. IUBMB Life. 2008;60:575-590.
15. Holtzmann J, Polosan M, Baro P, et al. ECT: from neuronal plasticity to mechanisms underlying antidepressant medication effect. Encephale. 2007;33:572-578. Review. French.
16. Taylor SM. Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J ECT. 2008;24:160-165.
17. Geschwind DH, Loginov M, Stern JM. Identification of a locus on chromosome 14 q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet. 1999;65:764-772.
18. Oliveira JR, Sobrido MJ, Spiteri E, et al. Analysis of candidate genes at the IBGC1 locus associated with idiopathic basal ganglia calcification ("Fahr's disease"). J Mol Neurosci. 2007;33:151-154.
19. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008;213:93-118. Epub 2008 Aug 13.
20. Strakowski SM, Delbello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry. 2005;10:105-116. Review.
21. Howes OD, Montgomery AJ, Asselin MC, et al. Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry. 2007;51(suppl): 13-18. Review.
22. Laviolette SR. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia? Schizophr Bull. 2007;33:971-981. Epub 2007 May 22. Review.